PL340837A1 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- PL340837A1 PL340837A1 PL98340837A PL34083798A PL340837A1 PL 340837 A1 PL340837 A1 PL 340837A1 PL 98340837 A PL98340837 A PL 98340837A PL 34083798 A PL34083798 A PL 34083798A PL 340837 A1 PL340837 A1 PL 340837A1
- Authority
- PL
- Poland
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704546A SE9704546D0 (en) | 1997-12-05 | 1997-12-05 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL340837A1 true PL340837A1 (en) | 2001-02-26 |
Family
ID=20409283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98340837A PL340837A1 (en) | 1997-12-05 | 1998-12-01 | Novel compounds |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1037889A1 (en) |
| JP (1) | JP2001525406A (en) |
| KR (1) | KR20010032800A (en) |
| CN (1) | CN1284074A (en) |
| AU (1) | AU1791599A (en) |
| BR (1) | BR9813378A (en) |
| CA (1) | CA2312357A1 (en) |
| EE (1) | EE200000321A (en) |
| HU (1) | HUP0100731A3 (en) |
| IL (1) | IL136368A0 (en) |
| NO (1) | NO20002787L (en) |
| PL (1) | PL340837A1 (en) |
| SE (1) | SE9704546D0 (en) |
| SK (1) | SK8442000A3 (en) |
| TR (1) | TR200001544T2 (en) |
| WO (1) | WO1999029686A1 (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9901875D0 (en) * | 1999-05-25 | 1999-05-25 | Astra Pharma Prod | Novel compounds |
| SE9904505D0 (en) | 1999-12-09 | 1999-12-09 | Astra Pharma Prod | Novel compounds |
| SE9904652D0 (en) * | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
| TWI258462B (en) | 1999-12-17 | 2006-07-21 | Astrazeneca Ab | Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same |
| JP2002330787A (en) * | 2000-10-21 | 2002-11-19 | Astrazeneca Ab | Chemical substance |
| WO2003042190A1 (en) | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
| PA8557501A1 (en) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | BENZAMIDA, HETEROARILAMIDA AND INVESTED AMIDAS |
| US7071223B1 (en) | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
| PA8591801A1 (en) | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | BENZAMID INHIBITORS OF THE P2X7 RECEIVER. |
| DE602004005033T2 (en) | 2003-05-12 | 2007-08-09 | Pfizer Products Inc., Groton | BENZAMIDINHIBITORS OF THE P2X7 RECEPTOR |
| GB0324498D0 (en) | 2003-07-21 | 2003-11-26 | Aventis Pharma Inc | Heterocyclic compounds as P2X7 ion channel blockers |
| AU2005258911A1 (en) | 2004-06-29 | 2006-01-12 | Pfizer Products Inc. | Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3H`1,2,4!triazin-2-YL!-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
| EP2001474B1 (en) | 2006-03-16 | 2016-03-09 | Second Genome, Inc. | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| TWI464148B (en) | 2006-03-16 | 2014-12-11 | Evotec Us Inc | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| BRPI0709596A2 (en) | 2006-03-16 | 2011-07-19 | Renovis Inc | bicycloetheroyl compounds as p2x7 modulators and their uses |
| TW200813018A (en) | 2006-06-09 | 2008-03-16 | Astrazeneca Ab | Novel compounds |
| GB0613473D0 (en) * | 2006-07-06 | 2006-08-16 | Glaxo Group Ltd | Novel compounds |
| MX2009000117A (en) | 2006-07-06 | 2009-01-23 | Glaxo Group Ltd | Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use. |
| WO2008112205A1 (en) | 2007-03-09 | 2008-09-18 | Renovis, Inc. | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| JP2010522711A (en) * | 2007-03-28 | 2010-07-08 | グラクソ グループ リミテッド | Piperidinone carboxamide derivatives as P2X7 modulators |
| WO2008119685A2 (en) * | 2007-03-29 | 2008-10-09 | Glaxo Group Limited | Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators |
| KR20090127435A (en) | 2007-04-03 | 2009-12-11 | 글락소 그룹 리미티드 | Imidazolidine carboxamide derivatives as p2x7 modulators |
| US8119661B2 (en) | 2007-09-11 | 2012-02-21 | Astrazeneca Ab | Piperidine derivatives and their use as muscarinic receptor modulators |
| GB0803729D0 (en) * | 2008-02-29 | 2008-04-09 | Ge Healthcare Ltd | Imaging the central nervous system |
| EA022505B1 (en) | 2008-03-25 | 2016-01-29 | Эффектис Фармасьютиклз Аг | Novel p2x7r antagonists and their use |
| PL2243772T3 (en) | 2009-04-14 | 2012-05-31 | Affectis Pharmaceuticals Ag | Novel P2X7R antagonists and their use |
| EP2322149A1 (en) | 2009-11-03 | 2011-05-18 | Universidad del Pais Vasco | Methods and compositions for the treatment of ischemia |
| US20130060047A1 (en) | 2010-05-14 | 2013-03-07 | Affectis Pharmaceuticals Ag | Novel methods for the preparation of p2x7r antagonists |
| WO2012110190A1 (en) | 2011-02-17 | 2012-08-23 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2012163792A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2012163456A1 (en) | 2011-05-27 | 2012-12-06 | Affectis Pharmaceuticals Ag | Novel p2x7r antagonists and their use |
| WO2019102354A1 (en) | 2017-11-21 | 2019-05-31 | 3M Innovative Properties Company | Oral plant-based-oil-in-water emulsions and methods of use |
| WO2019123171A1 (en) | 2017-12-20 | 2019-06-27 | 3M Innovative Properties Company | Oral compositions and methods of use |
| US11324681B2 (en) | 2017-12-20 | 2022-05-10 | 3M Innovative Properties Company | Oral compositions and methods of use |
-
1997
- 1997-12-05 SE SE9704546A patent/SE9704546D0/en unknown
-
1998
- 1998-12-01 IL IL13636898A patent/IL136368A0/en unknown
- 1998-12-01 CN CN98813490A patent/CN1284074A/en active Pending
- 1998-12-01 PL PL98340837A patent/PL340837A1/en unknown
- 1998-12-01 WO PCT/SE1998/002190 patent/WO1999029686A1/en not_active Application Discontinuation
- 1998-12-01 KR KR1020007006117A patent/KR20010032800A/en not_active Application Discontinuation
- 1998-12-01 JP JP2000524280A patent/JP2001525406A/en not_active Withdrawn
- 1998-12-01 SK SK844-2000A patent/SK8442000A3/en unknown
- 1998-12-01 EP EP98962753A patent/EP1037889A1/en not_active Withdrawn
- 1998-12-01 CA CA002312357A patent/CA2312357A1/en not_active Abandoned
- 1998-12-01 EE EEP200000321A patent/EE200000321A/en unknown
- 1998-12-01 BR BR9813378-0A patent/BR9813378A/en not_active Application Discontinuation
- 1998-12-01 TR TR2000/01544T patent/TR200001544T2/en unknown
- 1998-12-01 AU AU17915/99A patent/AU1791599A/en not_active Abandoned
- 1998-12-01 HU HU0100731A patent/HUP0100731A3/en unknown
-
2000
- 2000-05-31 NO NO20002787A patent/NO20002787L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001525406A (en) | 2001-12-11 |
| CN1284074A (en) | 2001-02-14 |
| HUP0100731A2 (en) | 2002-05-29 |
| KR20010032800A (en) | 2001-04-25 |
| SE9704546D0 (en) | 1997-12-05 |
| EP1037889A1 (en) | 2000-09-27 |
| AU1791599A (en) | 1999-06-28 |
| EE200000321A (en) | 2001-08-15 |
| TR200001544T2 (en) | 2000-11-21 |
| NO20002787D0 (en) | 2000-05-31 |
| SK8442000A3 (en) | 2001-01-18 |
| NO20002787L (en) | 2000-08-01 |
| CA2312357A1 (en) | 1999-06-17 |
| IL136368A0 (en) | 2001-06-14 |
| WO1999029686A1 (en) | 1999-06-17 |
| BR9813378A (en) | 2000-10-10 |
| HUP0100731A3 (en) | 2002-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24412A (en) | Novel compounds | |
| EG24177A (en) | Novel compounds | |
| GB9701684D0 (en) | Novel compounds | |
| GB9706255D0 (en) | Novel compounds | |
| GB9707830D0 (en) | Novel compounds | |
| GB9703492D0 (en) | Novel compounds | |
| GB9705619D0 (en) | Novel compounds | |
| GB9706525D0 (en) | Novel compounds | |
| GB9700689D0 (en) | Novel compounds | |
| GB9700694D0 (en) | Novel compounds | |
| GB9700901D0 (en) | Novel compounds | |
| GB9700902D0 (en) | Novel compounds | |
| GB9701597D0 (en) | Novel compounds | |
| GB9700687D0 (en) | Novel compounds | |
| GB9703011D0 (en) | Novel compounds | |
| GB9703333D0 (en) | Novel compounds | |
| GB9703334D0 (en) | Novel compounds | |
| GB9709085D0 (en) | Novel compounds | |
| GB9703491D0 (en) | Novel compounds | |
| GB9700591D0 (en) | Novel compounds | |
| GB9703493D0 (en) | Novel compounds | |
| GB9704461D0 (en) | Novel compounds | |
| GB9704462D0 (en) | Novel compounds | |
| GB9705385D0 (en) | Novel compounds | |
| GB9708492D0 (en) | Novel compounds |